FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy

Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer

(2021) Rui-Tao Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Pyroptosis in diabetic nephropathy

(2021) Abdullah Al Mamun et al.   CLINICA CHIMICA ACTA

NF-κB System Is Chronically Activated and Promotes Glomerular Injury in Experimental Type 1 Diabetic Kidney Disease

(2020) Orestes Foresto-Neto et al.   Frontiers in Physiology

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

(2020) Sandra Rayego-Mateos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches

(2020) Chetan Ram et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Glycogen synthase kinase‐3β inhibits tubular regeneration in acute kidney injury by a FoxM1‐dependent mechanism

(2020) Sonali Sinha et al.   FASEB JOURNAL

Protective effect of isoliquiritigenin on experimental diabetic nephropathy in rats: Impact on Sirt-1/NFκB balance and NLRP3 expression

(2020) Sharifa Alzahrani et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20

(2020) X. Ding et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Long non-coding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3

(2020) Chunjian Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway

(2019) Huimin Yang et al.   Molecular Metabolism

Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1

(2019) Dong-Wei Liu et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Blockade of the Adenosine A3 Receptor Attenuates Caspase 1 Activation in Renal Tubule Epithelial Cells and Decreases Interleukins IL-1β and IL-18 in Diabetic Rats

(2019) Wallys Garrido et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The transcription factor FoxM1 activates Nurr1 to promote intestinal regeneration after ischemia/reperfusion injury

(2019) Guo Zu et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury

(2019) Monica Chang-Panesso et al.   JOURNAL OF CLINICAL INVESTIGATION

AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions

(2018) Davoud Sanajou et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Regulation of the master regulator FOXM1 in cancer

(2018) Guo-Bin Liao et al.   Cell Communication and Signaling

Glomerular mesangial cell and podocyte injuries in diabetic nephropathy

(2018) Chun-Wu Tung et al.   NEPHROLOGY

The role of the complement system in diabetic nephropathy

(2017) Allan Flyvbjerg   Nature Reviews Nephrology

The Inflammasome Drives GSDMD-Independent Secondary Pyroptosis and IL-1 Release in the Absence of Caspase-1 Protease Activity

(2017) Katharina S. Schneider et al.   Cell Reports

Classification and Differential Diagnosis of Diabetic Nephropathy

(2017) Chenyang Qi et al.   Journal of Diabetes Research

Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods

(2016) WAN-NING WANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis

(2016) Jian-Xia Shi et al.   Experimental and Therapeutic Medicine

Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion

(2015) Wan-ting He et al.   CELL RESEARCH

Mechanisms of inflammasome activation: recent advances and novel insights

(2015) Sivapriya K. Vanaja et al.   TRENDS IN CELL BIOLOGY

SIRT4 Suppresses Inflammatory Responses in Human Umbilical Vein Endothelial Cells

(2014) Yu Tao et al.   Cardiovascular Toxicology

SIRT4 inhibits cigarette smoke extracts-induced mononuclear cell adhesion to human pulmonary microvascular endothelial cells via regulating NF-κB activity

(2014) Yongfeng Chen et al.   TOXICOLOGY LETTERS

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes

(2014) Yoshiro Maezawa et al.   Journal of Diabetes Investigation

NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury indb/dbmice

(2013) Li Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics

(2013) Francesca Conserva et al.   JOURNAL OF NEPHROLOGY

Targeting FOXM1 in cancer

(2012) Marianna Halasi et al.   BIOCHEMICAL PHARMACOLOGY

Inflammation and the pathogenesis of diabetic nephropathy

(2012) Jun Wada et al.   CLINICAL SCIENCE

Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney

(2010) Shinji Kume et al.   JOURNAL OF CLINICAL INVESTIGATION

 -Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1

(2008) A. Ackermann Misfeldt et al.   DIABETES